Related Experiment Video
Updated: Aug 21, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clinical characteristics among patients with COVID‑19: A single‑center retrospective study
Anjum Farhana1, Bilal Ahmad Tantry1, Naveed Nazir Shah2
1Department of Microbiology, Government Medical College, Srinagar, Jammu and Kashmir 190010, India.
Insights
Severe coronavirus disease 2019 (COVID-19) cases show distinct clinical and laboratory features. Key indicators include specific symptoms, elevated inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6), and lymphopenia.
Area of Science:
- Infectious Diseases
- Clinical Medicine
- Biochemistry
Background:
- Coronavirus disease 2019 (COVID-19) is a global health crisis.
- Understanding clinical and laboratory differences between severe and non-severe cases is crucial for patient management.
Purpose of the Study:
- To investigate the clinical features and laboratory parameters of hospitalized COVID-19 patients.
- To differentiate characteristics between severe and non-severe COVID-19 cases.
Main Methods:
- Retrospective analysis of clinical data from 1,096 hospitalized COVID-19 patients.
- Categorization into severe (626 patients) and non-severe (470 patients) groups.
- Statistical analysis using chi-square and Mann-Whitney U tests to compare groups.
Main Results:
- Severe COVID-19 cases presented with anosmia, sore throat, fatigue, headache, and shortness of breath.
- Significantly elevated C-reactive protein (CRP) and interleukin-6 (IL-6) levels were observed in severe cases.
- Hypertension was a more frequent comorbidity in severe COVID-19 patients, alongside significant lymphopenia.
Conclusions:
- Hospitalized patients with severe COVID-19 exhibit notable clinical symptoms and laboratory abnormalities.
- Elevated inflammatory markers (CRP, IL-6) and lymphopenia are key indicators of disease severity.
- Hypertension is a significant comorbidity associated with severe COVID-19 outcomes.
Abstract:
The aim of the present study was to investigate the clinical features and laboratory parameters of hospitalized patients with coronavirus disease 2019 (COVID-19) and assess the characteristics between severe and non-severe cases. The study retrospectively analyzed the clinical data of 1,096 patients, of which, 626 (57.11%) and 470 (42.89%) were categorized into severe and non-severe groups, respectively. Clinical parameters such as signs and symptoms, comorbidities, levels of D-dimer, C-reactive protein (CRP), interleukin 6 (IL-6) and lactate dehydrogenase were analyzed. The data are presented as frequencies, means and standard deviations. The chi-square test and Mann-Whitney U test were used to assess any significant differences between the severe and non-severe COVID-19 groups. The clinical symptoms in severe COVID-19 cases included anosmia (P≤0.01), sore throat (P≤0.01), fatigue (P≤0.01), headache (P≤0.01), and shortness of breath (P≤0.01). Laboratory findings showed a significant increase in CRP (21.90±40.23 vs. 16.13±21.82; P≤0.01) and IL-6 levels (58.92±55.07 vs. 41.41±38.30; P≤0.01). Patients with severe COVID-19 had significant lymphopenia compared with that in non-severe cases. Among the comorbidities, hypertension (P≤0.01) was significantly more frequent in patients with severe COVID-19. In conclusion, major derangements in laboratory parameters were observed in patients with severe COVID-19 infection.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Acute Coronary Syndrome III: Diagnostic Studies
Acute Pyelonephritis II: Diagnostic Studies and Management
Case Studies

